Detalhe da pesquisa
1.
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.
Nat Commun;
15(1): 2007, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38453922
2.
Antibody blockade of Jagged1 attenuates choroidal neovascularization.
Nat Commun;
14(1): 3109, 2023 05 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37253747
3.
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Int J Retina Vitreous;
9(1): 65, 2023 Nov 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37936232
4.
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.
PNAS Nexus;
2(12): pgad403, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38077689
5.
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life.
Commun Biol;
5(1): 832, 2022 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35982144
6.
Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study.
BMJ Open Ophthalmol;
6(1): e000764, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34485702
7.
A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes.
Sci Rep;
9(1): 18021, 2019 12 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31792234